Skip to content

Thoracic epidural anesthesia with ropivacaine: effects of age on neural blockade and cardiovascular parameters

Thoracic epidural anesthesia with ropivacaine: effects of age on neural blockade and cardiovascular parameters - Age effects in thoracic epidural anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33234
Enrollment
75
Registered
2009-07-06
Start date
2009-09-21
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lokaal anestheticum gebruikt voor epidurale anesthesie lung cancer pneumothorax

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: male and female patients ASA I-III patients undergoing thoracic surgery under thoracic epidural anesthesia

Exclusion criteria

Exclusion criteria: Diabetes mellitus Infection of the skin in the area of the epidural site A history of neurological diseases A history of bleeding diathesis Muscle diseases Hypersensitive to local anesthetics Pregnancy or lactation Participation in a trial on investigational drugs within 3 months prior to the study

Design outcomes

Primary

MeasureTime frame
Neural blockade: Time to initial onset of analgesia at the T3-T4 dermatomes Time to initial onset of motor blockade Time until maximum cephalad spread of analgesia Time until maximum caudad spread of analgesia Highest level of analgesia Maximum numbers of segments blocked Maximum score of motor block (Bromage scale and ESSAM score) Cardiovascular: Left ventricle systolic function Left ventricle diastolic function right ventricle systolic function

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)